BridgeMD
New treatment option for Osteoarthritis, Knee
Official title Analysis of the Pathophysiological and Functional State of the Knee Joint
ClinicalTrials.gov ID: NCT06490770
What this study is testing
- What it's testing
- Osteoarthritis is the most common degenerative condition affecting the knee joint globally, with an incidence of about 7% of the population. In Italy, it affects approximately 3.9 million people, with a direct treatment cost of around €2.5 billion.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 60
You may be able to join if
- Knee pain and/or loss of functionality
- Kellgren-Lawrence grade less than or equal to 2
- Arthroscopic evidence of cartilage tissue lesions
- Evidence of cartilage and/or meniscal tissue degeneration and/or subchondral bone marrow lesions
You likely can't join if
- History/evidence of previous partial or total knee prosthesis interventions
- Inability to provide informed consent
- Conditions or physical disorders incompatible with the use of MRI and electrical stimulation (implanted active and passive biomedical devices...
The study team makes the final eligibility decision.
Where it's taking place
- Bologna, Italy
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 60 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Bologna, Italy. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.